ICON, Asclepion-Meditec Ink Strategic Partnership
TORONTO, Ontario, Canada, Jan. 10 -- ICON Laser Eye Centers Inc. and Asclepion-Meditec AG of Germany have signed a letter of intent to enter into a strategic supplier agreement. the deal will help ICON expand its presence in the laser vision correction (LVC) industry within North America and Europe, the company said.
ICON will purchase an initial quantity of MEL 70 G-Scan lasers and receive access to the latest developments in excimer laser vision correction, including recent custom ablation system additions based on topography and wavefront technology. In addition, ICON will conduct US Food and Drug Administration studies with Asclepion, and be granted access to Asclepion's newest custom ablation and wavefront packages. Further details will be released after both parties reach a definitive agreement.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024